Cathie Wood’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.5M Buy
170,923
+44,740
+35% +$591K 0.02% 134
2026
Q1
$1.74M Buy
126,183
+12,117
+11% +$183K 0.01% 142
2025
Q4
$2.06M Sell
114,066
-19,452
-15% -$349K 0.01% 147
2025
Q3
$2.47M Buy
133,518
+47,455
+55% +$745K 0.01% 143
2025
Q2
$1.38M Buy
86,063
+1,363
+2% +$24.3K 0.01% 162
2025
Q1
$1.65M Sell
84,700
-14,123
-14% -$297K 0.02% 150
2024
Q4
$2.18M Sell
98,823
-61,802
-38% -$1.19M 0.02% 130
2024
Q3
$2.7M Sell
160,625
-47,898
-23% -$711K 0.02% 123
2024
Q2
$2.49M Sell
208,523
-48,977
-19% -$547K 0.02% 138
2024
Q1
$2.85M Sell
257,500
-3,211
-1% -$32.8K 0.02% 145
2023
Q4
$2.26M Sell
260,711
-33,020
-11% -$257K 0.01% 168
2023
Q3
$2.25M Sell
293,731
-69,873
-19% -$524K 0.02% 159
2023
Q2
$2.62M Sell
363,604
-140,894
-28% -$821K 0.02% 150
2023
Q1
$3.07M Buy
504,498
+32,019
+7% +$174K 0.02% 135
2022
Q4
$2.06M Buy
472,479
+48,280
+11% +$216K 0.02% 178
2022
Q3
$1.66M Buy
424,199
+24,243
+6% +$122K 0.01% 205
2022
Q2
$1.93M Sell
399,956
-9,628
-2% -$50.1K 0.01% 200
2022
Q1
$2.62M Buy
+409,584
New +$2.72M 0.01% 190

Other funds holding CLBT

Cathie Wood's CLBT Position: Q2 2026 in Review

Cathie Wood increased its Cellebrite (CLBT) stake by 35% in Q2 2026, buying an estimated $591K and bringing the position to 170,923 shares worth $2.5M. The position accounts for 0.02% of the portfolio, ranked #134.

Cathie Wood first reported a position in CLBT in Q1 2022 and has held it in 18 quarters since. The position peaked at $3.07M in Q1 2023. 200 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Cathie Wood held 170,923 shares of Cellebrite worth $2.5M as of Q2 2026.
  • Cathie Wood bought 44,740 Cellebrite shares in Q2 2026, an estimated $591K.
  • Cellebrite made up 0.02% of Cathie Wood's portfolio in Q2 2026, its #134 holding.
  • Cathie Wood first reported a position in Cellebrite in Q1 2022 and has held it in 18 quarters since.
  • Cathie Wood's Cellebrite position peaked at $3.07M in Q1 2023.
  • 200 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on ARK Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.